Yizhun-ai.com
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Yizhun-ai.com - overview
Established
2017
Location
Beijing, -, China
Primary Industry
Healthcare
About
Based in Beijing, China and established in 2017, Yizhun-ai. com is a medical service provider that focuses on providing medical imaging diagnosis services bases on AI technology. In 2018, the company launched the pulmonary nodule intelligent inspection system V1. 0.
In 2019, it released Darwin Intelligent Research Platform 1. 0. In 2020, the company released the new coronary pneumonia intelligent analysis system. The company’s partners include Beijing Hospital, Beijing Cancer Hospital, Shanghai Huadong Hospital, etc.
The company's products include chest CT intelligent analysis system, chest DR analysis system, breast ultrasound intelligent analysis system, breast X-ray intelligent analysis system and intelligent scientific research platform, providing intelligent analysis solutions from screening, management to diagnostic analysis.
Current Investors
Hina Group, AA Investment, Qingsong Fund
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Healthcare IT, Diagnostic Equipment, Web Applications, Medical Software
Website
www.yizhun-ai.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Series C
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.